G. Velikova et al., Self-reported quality of life of individual cancer patients: Concordance of results with disease course and medical records, J CL ONCOL, 19(7), 2000, pp. 2064-2073
Purpose: To investigate the applicability of a standard quality of life (QL
) questionnaire to individual cancer patients and to explore the potential
for impact of QL information on the process of care by comparing at group l
evel the QL results with the medical records.
Patients and Methods: One hundred fourteen consecutive patients at the onco
logy clinics at St James's Hospital, Leeds, United Kingdom, completed the E
uropean: Organisation for the Research and Treatment of Cancer (EORTC) Qual
ity of Life Questionnaire (QLQ)-C30 on a touch-screen computer over a 6-mon
th period. The QL results were compared with the corresponding medical reco
rds at individual and group level.
Results: For individual patients, the serial measurement of QL allowed reco
gnition of patterns over time corresponding to disease course. At group lev
el, a higher proportion of patients reported problems on EORTC QLQ-C30 than
were mentioned in the medical records (McNemar paired test, P < .01), Most
often clinicians mentioned pain (22% to 39%), and at the initial visit rol
e (66%), and social issues (77%). For the rest of the symptoms and function
s, the problems were recorded in between 1% and 25% of the notes, but 20% t
o 76% of the patients reported QL impairment. Problems that were not record
ed in the medical notes tended to be of low severity, with ct significant t
rend observed for pain, fatigue, nausea/vomiting, dyspnea, loss of appetite
, and physical function scale (<chi>(2) test, 11.55 to 34.42, df = 1, P < .
001).
Conclusion: The QL data on individual patients was consistent with the clin
ical records, thus providing evidence for the validity of these measures in
assessment of the individual. The QL profiles had more information on symp
toms and particularly on functional issues, such as emotional distress and
physical performance. <(c)> 2001 by American Society of Clinical Oncology.